Annual Operating Profit
-$86.42 M
-$100.95 M-694.41%
31 December 2023
Summary:
Cartesian Therapeutics annual operaing income is currently -$86.42 million, with the most recent change of -$100.95 million (-694.41%) on 31 December 2023. During the last 3 years, it has fallen by -$81.82 million (-1779.83%). RNAC annual operating profit is now -694.41% below its all-time high of $14.54 million, reached on 31 December 2022.RNAC Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$17.57 M
-$31.33 M-227.75%
01 September 2024
Summary:
Cartesian Therapeutics quarterly operating income is currently -$17.57 million, with the most recent change of -$31.33 million (-227.75%) on 01 September 2024. Over the past year, it has dropped by -$4.51 million (-34.52%). RNAC quarterly operating profit is now -226.80% below its all-time high of $13.86 million, reached on 01 June 2022.RNAC Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$53.50 M
-$4.51 M-9.21%
01 September 2024
Summary:
Cartesian Therapeutics TTM operating income is currently -$53.50 million, with the most recent change of -$4.51 million (-9.21%) on 01 September 2024. Over the past year, it has increased by +$5.08 million (+8.68%). RNAC TTM operating profit is now -297.32% below its all-time high of $27.11 million, reached on 01 September 2022.RNAC TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RNAC Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -694.4% | -34.5% | +8.7% |
| 3 y3 years | -1779.8% | -531.0% | -1063.8% |
| 5 y5 years | -64.7% | -39.8% | -2.0% |
RNAC Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -694.4% | at low | -226.8% | +51.6% | -297.3% | +38.1% |
| 5 y | 5 years | -694.4% | at low | -226.8% | +51.6% | -297.3% | +38.1% |
| alltime | all time | -694.4% | at low | -226.8% | +51.6% | -297.3% | +38.1% |
Cartesian Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$17.57 M(-227.8%) | -$53.50 M(+9.2%) |
| June 2024 | - | $13.76 M(-203.1%) | -$48.99 M(-39.8%) |
| Mar 2024 | - | -$13.35 M(-63.3%) | -$81.38 M(-5.8%) |
| Dec 2023 | -$86.42 M(-694.4%) | -$36.33 M(+178.1%) | -$86.42 M(+47.5%) |
| Sept 2023 | - | -$13.06 M(-29.9%) | -$58.58 M(+24.3%) |
| June 2023 | - | -$18.64 M(+1.4%) | -$47.11 M(+222.3%) |
| Mar 2023 | - | -$18.38 M(+116.3%) | -$14.62 M(-200.5%) |
| Dec 2022 | $14.54 M(-416.2%) | - | - |
| Dec 2022 | - | -$8.50 M(+431.3%) | $14.54 M(-46.4%) |
| Sept 2022 | - | -$1.60 M(-111.5%) | $27.11 M(+1.4%) |
| June 2022 | - | $13.86 M(+28.7%) | $26.74 M(+100.6%) |
| Mar 2022 | - | $10.77 M(+164.2%) | $13.33 M(-390.1%) |
| Dec 2021 | -$4.60 M(-91.9%) | $4.08 M(-307.1%) | -$4.60 M(-72.3%) |
| Sept 2021 | - | -$1.97 M(-535.6%) | -$16.57 M(-41.5%) |
| June 2021 | - | $452.00 K(-106.3%) | -$28.34 M(-37.2%) |
| Mar 2021 | - | -$7.16 M(-9.4%) | -$45.16 M(-20.5%) |
| Dec 2020 | -$56.82 M(+8.3%) | -$7.90 M(-42.5%) | -$56.82 M(-7.6%) |
| Sept 2020 | - | -$13.73 M(-16.1%) | -$61.49 M(+3.3%) |
| June 2020 | - | -$16.37 M(-13.0%) | -$59.55 M(+0.2%) |
| Mar 2020 | - | -$18.82 M(+49.7%) | -$59.42 M(+13.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$52.45 M(-19.3%) | -$12.57 M(+6.6%) | -$52.45 M(-3.5%) |
| Sept 2019 | - | -$11.79 M(-27.4%) | -$54.38 M(-7.1%) |
| June 2019 | - | -$16.23 M(+36.9%) | -$58.53 M(-4.1%) |
| Mar 2019 | - | -$11.86 M(-18.2%) | -$61.06 M(-6.1%) |
| Dec 2018 | -$65.02 M(+1.9%) | -$14.50 M(-9.0%) | -$65.02 M(-6.8%) |
| Sept 2018 | - | -$15.94 M(-15.1%) | -$69.80 M(+3.1%) |
| June 2018 | - | -$18.77 M(+18.7%) | -$67.71 M(+4.5%) |
| Mar 2018 | - | -$15.81 M(-18.0%) | -$64.81 M(+1.6%) |
| Dec 2017 | -$63.78 M(+84.0%) | -$19.28 M(+39.1%) | -$63.78 M(+9.3%) |
| Sept 2017 | - | -$13.85 M(-12.7%) | -$58.37 M(+12.3%) |
| June 2017 | - | -$15.87 M(+7.4%) | -$51.98 M(+22.3%) |
| Mar 2017 | - | -$14.78 M(+6.7%) | -$42.51 M(+22.6%) |
| Dec 2016 | -$34.67 M(+37.0%) | -$13.86 M(+85.6%) | -$34.67 M(+24.2%) |
| Sept 2016 | - | -$7.47 M(+16.7%) | -$27.92 M(+5.3%) |
| June 2016 | - | -$6.40 M(-7.8%) | -$26.52 M(+0.3%) |
| Mar 2016 | - | -$6.94 M(-2.3%) | -$26.43 M(+4.5%) |
| Dec 2015 | -$25.30 M(+64.3%) | -$7.11 M(+17.1%) | -$25.30 M(+39.1%) |
| Sept 2015 | - | -$6.07 M(-3.9%) | -$18.20 M(+50.1%) |
| June 2015 | - | -$6.32 M(+8.7%) | -$12.13 M(+108.7%) |
| Mar 2015 | - | -$5.81 M | -$5.81 M |
| Dec 2014 | -$15.40 M | - | - |
FAQ
- What is Cartesian Therapeutics annual operaing income?
- What is the all time high annual operating profit for Cartesian Therapeutics?
- What is Cartesian Therapeutics annual operating profit year-on-year change?
- What is Cartesian Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Cartesian Therapeutics?
- What is Cartesian Therapeutics quarterly operating profit year-on-year change?
- What is Cartesian Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Cartesian Therapeutics?
- What is Cartesian Therapeutics TTM operating profit year-on-year change?
What is Cartesian Therapeutics annual operaing income?
The current annual operating profit of RNAC is -$86.42 M
What is the all time high annual operating profit for Cartesian Therapeutics?
Cartesian Therapeutics all-time high annual operaing income is $14.54 M
What is Cartesian Therapeutics annual operating profit year-on-year change?
Over the past year, RNAC annual operaing income has changed by -$100.95 M (-694.41%)
What is Cartesian Therapeutics quarterly operating income?
The current quarterly operating profit of RNAC is -$17.57 M
What is the all time high quarterly operating profit for Cartesian Therapeutics?
Cartesian Therapeutics all-time high quarterly operating income is $13.86 M
What is Cartesian Therapeutics quarterly operating profit year-on-year change?
Over the past year, RNAC quarterly operating income has changed by -$4.51 M (-34.52%)
What is Cartesian Therapeutics TTM operating income?
The current TTM operating profit of RNAC is -$53.50 M
What is the all time high TTM operating profit for Cartesian Therapeutics?
Cartesian Therapeutics all-time high TTM operating income is $27.11 M
What is Cartesian Therapeutics TTM operating profit year-on-year change?
Over the past year, RNAC TTM operating income has changed by +$5.08 M (+8.68%)